Clinical Trial Update: ATEM (Alvesco Non-interventional Study)

View source ↗

Summary

This update covers a completed non-interventional study of Alvesco (ciclesonide) in asthma and allergic conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Alvesco (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Allergy | Status: COMPLETED